Source: Health Canada shortage reports · Updated Jul 23, 2026
Also sold as: Xylocaine, Xylocard, Xylocaine Viscous, Xylocaine Jelly
Some Lidocaine products are in shortage in Canada (2 of 24 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer.
A local anesthetic used to numb an area of the body before minor procedures or to relieve pain.
Products affected
2 / 24
In shortage since
Jun 21, 2016
Reports on file
100
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Active shortage
LIDOCAINE HYDROCHLORIDE INJECTION USP
10MG · SOLUTION · PFIZER CANADA ULC
DIN 00884154 · since Dec 17, 2025, no end estimate · Disruption of the manufacture of the drug.
Active shortage
LIDOCAINE HYDROCHLORIDE INJECTION USP
10MG · SOLUTION · PFIZER CANADA ULC
DIN 00884154 · since Dec 1, 2021, no end estimate · Disruption of the manufacture of the drug.
Active shortage
LIDODAN JELLY 2%(SINGLE USE SYRINGE)
2% · JELLY · ODAN LABORATORIES LTD
DIN 02167603 · since Jun 21, 2016, no end estimate · Disruption of the manufacture of the drug.
Anticipated
LIDOCAINE HYDROCHLORIDE INJECTION USP
20MG · SOLUTION · FORMATIVE PHARMA INC.
DIN 02547856 · Requirements related to complying with good manufacturing practices.
Anticipated
LIDOCAINE HYDROCHLORIDE INJECTION USP
10MG · SOLUTION · FORMATIVE PHARMA INC.
DIN 02534827 · Requirements related to complying with good manufacturing practices.
Anticipated
LIDOCAINE HYDROCHLORIDE INJECTION USP
20MG · SOLUTION · PFIZER CANADA ULC
DIN 00436208 · Disruption of the manufacture of the drug.
Resolved
LIDOCAINE INJECTION BP
2% · SOLUTION · EUGIA PHARMA INC.
DIN 02530457 · ended May 7, 2026 · Requirements related to complying with good manufacturing practices.
Resolved
LIDOCAINE INJECTION BP
1% · SOLUTION · EUGIA PHARMA INC.
DIN 02530449 · ended May 7, 2026 · Requirements related to complying with good manufacturing practices.
Resolved
LIDOCAINE HYDROCHLORIDE INJECTION USP
10MG · SOLUTION · HIKMA CANADA LIMITED
DIN 02422018 · ended Jan 26, 2026 · Disruption of the manufacture of the drug.
Resolved
XYLOCAINE 1%
10MG · SOLUTION · ASPEN PHARMACARE CANADA INC.
DIN 00001732 · ended Dec 19, 2025 · Disruption of the manufacture of the drug.
Resolved
XYLOCAINE 1%
10MG · SOLUTION · ASPEN PHARMACARE CANADA INC.
DIN 00001732 · ended Dec 19, 2025 · Disruption of the manufacture of the drug.
Resolved
XYLOCAINE 1%
10MG · SOLUTION · ASPEN PHARMACARE CANADA INC.
DIN 00001732 · ended Oct 28, 2025 · Disruption of the manufacture of the drug.
Showing 12 of 60 reports. All reports are on file with Health Canada.
What's happening
Lidocaine is currently affected by 2 active shortage reports filed with Health Canada by PFIZER CANADA ULC, ODAN LABORATORIES LTD.
The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Lidocaine is classified under “ANTIARRHYTHMICS, CLASS I AND III” (ATC C01BB).
Recent changes
Jul 23, 2026
New report filed
Jul 23, 2026
New report filed
Common questions
What is Lidocaine used for?
A local anesthetic used to numb an area of the body before minor procedures or to relieve pain.
When will Lidocaine be back in stock in Canada?
Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.
Why is Lidocaine in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.